A comparative study of metabolic profile in pre-eclampsia and normotensive preterm pregnancy


  • Durgavathi Kothapalli Department of Obstetrics and Gynecology, Konaseema Institute of Medical Science Amalapuram, Andhra Pradesh, India
  • Kameswari Kolluru Department of Obstetrics and Gynecology, Konaseema Institute of Medical Science Amalapuram, Andhra Pradesh, India




Dyslipidemia, Insulin resistance, Preeclampsia


Background: Hypertensive disorders of pregnancy are important and common cause of severe acute morbidity, long-term disability and death among mothers and babies. The metabolic characteristics (hypertriglyceridemia, hyperinsulinemia, hyperuricemia, low HDL2 cholesterol) in pregnancy-induced hypertension resemble the main features of the “insulin resistance syndrome”. This may result in endothelial cell dysfunction as evidenced by PGI2 suppression. We have designed this study with an objective to compare the metabolic parameters like fasting and post prandial blood glucose, fasting plasma insulin, HOMA-IR and lipid profile between pre-eclampsia and normotensive pregnant women at late preterm (32-36 weeks).

Methods: Based on enrolment criteria and statistical analysis 224 patients were enrolled in study during study period and divided in to two groups, group 1- normotensive subjects, group2- pre-eclampsia subjects. Various biochemical parameters and obstetric profile was measured and compared with standard normotensive subjects.

Results: The mean fasting plasma insulin was significant higher in group 2 than group 1 (18.36±6.48 mIU/dl versus 3.42±1.68 mIU/dl) (p=0.0001). The mean value of HOMA-IR was significant higher in group 2 than group 1 (3.82±1.68 versus 1.98±1.68) (p=0.0001). The mean value of HDL was significant higher in group 1 than group 2 (42.56±3.28 mg/dl versus 34.26±3.63 mg/dl) (p=0.0001). The mean concentration of LDL was significant higher in group 2 than group 1 (142.23±24.36 mg/dl vrsus 84.32±18.24 mg/dl) (p=0.0001).

Conclusions: Systolic and diastolic blood pressure was significantly higher in preeclampsia patients and plasma fasting glucose was higher in normotensive subjects. In present study fasting plasma insulin and HOMA-IR are significantly higher in cases then control. Dyslipidemia is significantly evident in preeclampsia patients in our study.


Jeyabalan A. Epidemiology of preeclampsia: impact of obesity. Nutr Rev. 2013;71(1-01):S18-25.

Duley L. The global impact of pre-eclampsia and eclampsia. Semin Perinatol. 2009;33(3):130-7.

Steegers EA, von Dadelszen P, Duvekot JJ, Pijnenborg R. Pre-eclampsia. Lancet. 2010;376(9741):631-44.

Burton GJ, Redman CW, Roberts JM, Moffett A. Pre-eclampsia: pathophysiology and clinical implications. BMJ. 2019;366

Hauth JC, Clifton RG, Roberts JM, Myatt L, Spong CY, Leveno KJ, et al. Maternal insulin resistance and preeclampsia. Am J Obstet Gynecol. 2011;204:327.e1-6.

Kaaja R, Tikkanen MJ, Viinikka L, Ylikorkala O. Serum lipoproteins, insulin, and urinary prostanoid metabolites in normal and hypertensive pregnant women. Obstet Gynecol. 1995;85:353-6.

Thadhani R, Stampfer MJ, Hunter DJ, Manson JE, Solomon CG, Curhan GC. High body mass index and hypercholesterolemia: risk of hypertensive disorders of pregnancy. Obstet Gynecol. 1999;94:543-6.

D’Anna R, Baviera G, Corrado F, Giordano D, De Vivo A, Nicocia G, et al. Adiponectin and insulin resistance in early‐and late‐onset pre‐eclampsia. BJOG Int J Obstet Gynaecol. 2006;113(11):1264-9.

Barry DR, Utzschneider KM, Tong J, Gaba K, Leotta DF, Brunzell JD, et al. Intraabdominal fat, insulin sensitivity, and cardiovascular risk factors in postpartum women with a history of preeclampsia. Am J Obstet Gynecol. 2015;213(1):104.e1-11.

Bartha JL, Romero-Carmona R, Torrejon-Cardoso R, Comino-Delgado R. Insulin, insulin like growth factor-1, and insulin resistance in women with pregnancy-induced hypertension. Am J Obstet Gynecol. 2002;187:735-40.

Caruso A, Ferrazzani S, De Carolis S, Lucchese A, Lanzone A, De Santis L, et al. Gestational hypertension but not pre-eclampsia is associated with insulin resistance syndrome characteristics. Hum Reprod. 1999;14:219-23.

Stekkinger E, Zandstra M, Peeters LL, Spaanderman ME. Early-onset preeclampsia and the prevalence of postpartum metabolic syndrome. Obstet Gynecol. 2009;114:1076-84.

Conde-Agudelo A, Villar J, Lindheimer M. World Health Organization systematic review of screening tests for preeclampsia. Obstet Gynecol. 2004;104(6):1367-91.

Friedewald WT, Levy RI, Fredrickson DS. Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem. 1972;18(6):499-502.

Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC. Homeostasis model assessment: insulin resistance and β-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia. 1985;28(7):412-9.

Dhand NK, Khatkar MS. Statulator: An online statistical calculator. Sample Size Calculator for Comparing Two Independent Means. 2014. Available at: http://statulator.com/SampleSize/ss2M.html. Accessed 28 April 2021

Lamminpää R, Vehviläinen-Julkunen K, Gissler M, Heinonen S. Preeclampsia complicated by advanced maternal age: a registry-based study on primiparous women in Finland 1997-2008. BMC Pregnanc Childbirth. 2012;11(12):47.

Ramesh K, Gandhi S, Rao V. Socio-demographic and other risk factors of pre eclampsia at a tertiary care hospital, karnataka: case control study. J Clin Diagn Res. 2014;8(9):JC01-4.

Kirsten D, Deborah H. Risk factors for pre-eclampsia at antenatal booking: systematic review of controlled studies. BMJ. 2005;330:565

Motedayen M, Rafiei M, Rezaei Tavirani M, Sayehmiri K, Dousti M. The relationship between body mass index and preeclampsia: A systematic review and meta-analysis. Int J Reprod Biomed. 2019;17(7):463-72.

Singh MM. Carbohydrate metabolism in pre-eclampsia. Br J Obstet Gynaecol. 1976;83(2):124-31.

Abhari FR, Ghanbari Andarieh M, Farokhfar A, Ahmady S. Estimating rate of insulin resistance in patients with preeclampsia using HOMA-IR index and comparison with nonpreeclampsia pregnant women. BioMed Res Int. 2014;2014.

Sinha S, Singh GP, Gupta K, Kumar S, Gupta A. Effect of preeclampsia on insulin sensitivity. Int J Appl Basic Med Res. 2014;4(1):7-10.

Gohil JT, Patel PK, Gupta P. Estimation of lipid profile in subjects of preeclampsia. J Obstet Gynaecol India. 2011;61(4):399-403.

Mikhail MS, Basu J, Palan PR, Furgiuele J, Romney SL, Anyaegbunam A. Lipid profile in women with preeclampsia: relationship between plasma triglyceride levels and severity of preeclampsia. J Assoc Acad Minor Phys. 1995;6(1):43-5.






Original Research Articles